Improved systems and methods for medicine delivery, and in particular, improved insulin pen needles and related devices are provided. Smart injection devices record and transfer data including medicine level, delivered dose, dose confirmation, and dose time and date. Additional data captured may include glucose concentration, insulin level, carbohydrates ingested, stress level, exercise, blood pressure, and glucose high and low excursion events. Various means of data collection and analysis are provided and systems can identify and flag patients who require intervention. Smart sleeves and add sensing capability to standard insulin pens. Pen needles are provided with sensing capability to confirm and measure doses delivered by insulin pen. A two-part pen cap include a primary sleeve that connects to the insulin pen and an end cap that provides for capturing the time of dose delivery, and monitoring the hold time for a dose delivery after plunger movement.

A pre-loaded container and a method of manufacturing a preloaded vial is provided wherein one or more active agents is lyophilized within the vial cap and the vial cap is then sealed onto a vial retaining a suitable diluent to form the pre-loaded vial. Lyophilizing the one or more active agents within the vial cap ensures that the one or more active agents are retained in sterile conditions, that the lyophilized one or more active agents and the diluent may be stored efficiently, and that the one or more active agents may be solubilized in a sterile and efficient manner.

Package block (3, 5) consisting of individual packages (1, 2) that are mechanically coupled together and can be separated from one another by a shear force acting along the respective parting joint (11) and can be sealed medically tight at least in the vicinity of their container openings (14) by a continuous label strip (17), wherein the continuous label strip (17) consists of individual labels (18-20) connected to one another across parting edges (32), and that the parting edges (32) are aligned with the parting joints (11) between the individual packages (1, 2).

A closure for a medical container including a base structured to be supported in an operative, upright orientation on a horizontal surface and having an exposed face and a connector disposed thereon and extending outwardly therefrom. A protective cage includes one or more cage members each configured in the form of a helix fixedly connected to the base and extending longitudinally and laterally outward from the connector in at least partially surrounding relation thereto. The base may include self-righting structural features, including an outer surface having a curved, substantially bulbous configuration and a center of gravity disposed between a tipping point of said base and a terminal end thereof.

The present invention provides, medical rubber parts that do not physically and chemically affect the quality of preparations. The present invention relates to a medical rubber part obtained by press-molding an unvulcanized rubber mainly containing a rubber for forming a liquid-contacting portion and an unvulcanized rubber mainly containing a butyl-based rubber for forming a non-liquid-contacting portion, wherein a color difference dE between the liquid-contacting portion and the non-liquid-contacting portion is 6.0 or more in NBS units.

A thermoplastic elastomer composition including: 100 parts by mass of a hydrogenated block copolymer (a); from 10 to 50 parts by mass of a polypropylene resin (b); from 5 to 100 parts by mass of a polyphenylene ether resin (c); and from 75 to 200 parts by mass of a non-aromatic softener (d), wherein the hydrogenated block copolymer (a) contains a hydrogenated block copolymer (a-1) obtained by hydrogenation, the hydrogenated block copolymer (a-1) comprising at least one polymer block A1 including mainly a vinyl aromatic hydrocarbon compound monomer unit, and at least one polymer block B1 including mainly a conjugated diene compound monomer unit, a weight-average molecular weight of the hydrogenated block copolymer (a-1) is from 100,000 to 550,000, and a content of all vinyl aromatic hydrocarbon compound monomer units in the hydrogenated block copolymer (a-1) is more than 20% by mass and 50% by mass or less.

An injection vial and injection vial management system is disclosed, wherein the injection vial is filled with a liquid medicine and signally connected with a blockchain network. The injection vial includes a bottle body and a chipset disposed within the bottle body. The chipset includes an identification label and a blockchain module. The identification label records a manufacturing process, a logistic process and a use process. The blockchain module signal connects to the blockchain network in order to record the manufacturing process, logistic process and use process in the blockchain network.

The disclosure is directed at an animal supplements and/or medication organizer that includes a tray and a plurality of containers containing the supplements and/or medication. The plurality of containers can be different sizes to hold the supplements and/or medication, either in a solid (powdered or liquid) form. The tray includes a predetermined number of sections for receiving the containers.

A closure for dispensing one or more active agents into a container comprises a sealed or sealable chamber having a breakable wall and a hollow piston slidably mounted in a piston guide. Said hollow piston comprises an outer wall having an end in the chamber and at least one ventilation aperture. Said end has a cutting formation. Said hollow piston is slidable in the piston guide between a ventilation position in which the at least one ventilation aperture allows ventilation of the chamber and a sealed position in which the at least one ventilation aperture is sealed to prevent ventilation of the chamber and a deployed position in which the cutting formation has broken through at least a portion of the breakable wall. The outer wall has a retaining formation which engages with the piston guide to releasably resist sliding of the hollow piston between the ventilation position and the sealed position and the deployed position. The hollow piston may have an outer wall, and said outer wall has an end within the chamber, facing the breakable wall, wherein the cutting end has a first edge having a cutting formation and a gap in said cutting formation.

The present invention relates to a package, and more particularly to a package for sterile fluids, such as contrast media. More particularly the invention relates to a package comprising a container, a stopper (40), a cap (50) and a flip cover (60).